Chat with us, powered by LiveChat

Boehringer Ingelheim to buy Japanese consumer drug producer

German drug company Boehringer Ingelheim is in talks to make Japanese subsidiary SSP Co Ltd (4537.T) wholly-owned in a deal worth more than 30 billion yen ($335 million), the Nikkei newspaper reported.

Boehringer currently owns 60 percent of SSP, a maker of over-the-counter drugs.

Boehringer is expected to buy the remaining stake in a tender offer as early as the end of this month, the Nikkei said.